Pfizer plans to launch DTC promoting Lyrica for fibromyalgia in the fall, just five months after gaining approval for the condition under its “fast to market” strategy, the Pink Sheet reports.
From the September 01, 2007 Issue of MM+M - Medical Marketing and Media